Skip to main content
. 2020 Jul 12;31(12):2461–2471. doi: 10.1007/s00198-020-05513-x

Table 2.

Deterministic results

Discounted results Undiscounted results
Treatment Costs, USD Life-years QALYs Costs, USD Life-years QALYs
BKP versus CMM; inpatient (N = 2,071)
  CMM 32,324 2.95 1.47 32,901 3.17 1.58
  BKP inpatient 58,986 3.98 2.08 60,463 4.39 2.29
  Incremental 26,662 1.03 0.61 27,561 1.22 0.71
  ICER per LY 25,813 22,564
  ICER per QALY 43,455 38,661
BKP versus CMM; outpatient (N = 3,708)
  CMM 24,234 6.16 3.08 25,923 7.17 3.59
  BKP outpatient 32,972 7.50 3.88 35,829 8.96 4.63
  Incremental 8,738 1.34 0.80 9,906 1.80 1.05
  ICER per LY 6,544 5,508
  ICER per QALY 10,922 9,466
VP versus CMM; inpatient (N = 720)
  CMM 31,005 2.95 1.47 31,569 3.17 1.58
  VP inpatient 61,342 4.27 2.23 63,041 4.74 2.48
  Incremental 30,338 1.32 0.76 31,472 1.57 0.89
  ICER per LY 22,918 20,008
  ICER per QALY 39,774 35,240
VP versus CMM; outpatient (1,042)
  CMM 23,789 6.03 3.02 25,437 6.99 3.50
  VP outpatient 32,301 7.15 3.71 35,399 8.49 4.39
  Incremental 8,512 1.12 0.69 9,962 1.50 0.89
  ICER per LY 7,578 6,654
  ICER per QALY 12,293 11,151

BKP, balloon kyphoplasty; CMM, conservative medical management; ICER, incremental cost-effectiveness ratio; LY, life-year; QALY, quality-adjusted life-year; VP, vertebroplasty